Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer
31/08/2017
Authors: A. F. Schott, L. J. Goldstein, M. Cristofanilli, P. A. Ruffini, S. McCanna, J. M. Reuben, R. P. Perez, G. Kato, M. Wicha
Published in:
Clinical Cancer Research